Management Turnover as Change Agent

Showing posts with label Novartis AG. Show all posts
Showing posts with label Novartis AG. Show all posts

Monday, July 23, 2007

Novartis CEO Successor May Have Been Selected

According to an article in the Swiss weekly SonntagsZeitung, picked up by Forbes 7/23/07, Novartis AG NVS (NYSE) chief executive Daniel Vasella might propose current Vaccines & Diagnostics chief executive Joerg Reinhardt as his successor.